WBR0318: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) (Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Pathology |SubCategory=Neurology |MainCategory=Pathology |SubCategory=Neurology |MainCategory=Pathol...") |
No edit summary |
||
Line 20: | Line 20: | ||
|MainCategory=Pathology | |MainCategory=Pathology | ||
|SubCategory=Neurology | |SubCategory=Neurology | ||
|Prompt=A 6 month old | |Prompt=A 6-month-old male is brought by his mother to the physician's office for failure to thrive. Following appropriate work-up, that patient is diagnosed with a disease that is characterized by failure of mannose-6-phosphate addition to lysosomes. Which of the following clinical features are most likely to be present in this patient? | ||
|Explanation=The patient is most likely presenting with inclusion cell disease or I-cell disease (mucolipidosis type II), a lysosomal storage disease characterized by failure of mannose-6-phosphate to be added to lysosomes due to a defect of phosphotransferase, which is normally found on the Golgi apparatus. Consequently, enzymes will be secreted extracellularly rather than being targeted by the lysosome. Typical clinical features of I-cell disease are coarse facial features, restricted joint movement, and clouded corneas in very young children. The disease is usually deadly in childhood. | |Explanation=The patient is most likely presenting with inclusion cell disease or I-cell disease (mucolipidosis type II), a lysosomal storage disease characterized by failure of mannose-6-phosphate to be added to lysosomes due to a defect of phosphotransferase, which is normally found on the Golgi apparatus. Consequently, enzymes will be secreted extracellularly rather than being targeted by the lysosome. Typical clinical features of I-cell disease are coarse facial features, restricted joint movement, and clouded corneas in very young children. The disease is usually deadly in childhood. | ||